American Journal of Neuroradiology, Vol 13, Issue 4 1071-1077, Copyright © 1992 by American Society of Neuroradiology
ARTICLES |
Spinal MR findings in neurofibromatosis types 1 and 2
JC Egelhoff, DJ Bates, JS Ross, AD Rothner and BH Cohen
Department of Radiology, Cleveland Clinic Foundation, OH 44195.
PURPOSE: To evaluate the frequency and nature of spinal pathology, the frequency of clinically silent lesions, and the potential benefit of screening spinal MR in neurofibromatosis patients. PATIENTS AND METHODS: 28 neurofibromatosis type-1 (NF-1) patients and nine neurofibromatosis type-2 (NF-2) patients were studied with postcontrast spinal MR imaging. RESULTS: NF-1: One patient had a biopsy-proven low- grade glioma; five patients, intradural, extramedullary masses (N = 23); one patient, extradural masses (N = 2) (neurofibromas); 16 patients had bony abnormalities; and three patients thecal sac abnormalities. NF-2: Five patients demonstrated intramedullary masses (five/eight ependymomas); nine patients, intradural, extramedullary masses (meningiomas, schwannomas); and four patients, bony abnormalities. Eight/10 NF-1 and four/nine NF-2 patients had asymptomatic masses. CONCLUSION: Intradural disease is common, often asymptomatic, and often presents at a young age in NF-1 and NF-2 patients. Because of the propensity to develop significant asymptomatic as well as symptomatic intradural disease, screening of the entire spine with MR is recommended in both NF-1 and NF-2 patients.
This article has been cited by other articles:
![]() |
A. Drouet, P. Wolkenstein, J.-P. Lefaucheur, S. Pinson, P. Combemale, R. K. Gherardi, P. Brugieres, J. Salama, P. Ehre, P. Decq, et al. Neurofibromatosis 1-associated neuropathies: a reappraisal Brain, September 1, 2004; 127(9): 1993 - 2009. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Kehrer-Sawatzki, S Tinschert, and D E Jenne Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region J. Med. Genet., October 1, 2003; 40(10): e116 - 116. [Full Text] [PDF] |
||||
![]() |
L Messiaen, V Riccardi, J Peltonen, O Maertens, T Callens, S L Karvonen, E-L Leisti, J Koivunen, I Vandenbroucke, K Stephens, et al. Independent NF1 mutations in two large families with spinal neurofibromatosis J. Med. Genet., February 1, 2003; 40(2): 122 - 126. [Full Text] [PDF] |
||||
![]() |
N. J. Patronas, N. Courcoutsakis, C. M. Bromley, G. L. Katzman, M. MacCollin, and D. M. Parry Intramedullary and Spinal Canal Tumors in Patients with Neurofibromatosis 2: MR Imaging Findings and Correlation with Genotype Radiology, February 1, 2001; 218(2): 434 - 442. [Abstract] [Full Text] |
||||
![]() |
J. L. Rutkowski, K. Wu, D. H. Gutmann, P. J. Boyer, and E. Legius Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1 Hum. Mol. Genet., April 12, 2000; 9(7): 1059 - 1066. [Abstract] [Full Text] [PDF] |
||||



